J K Cements Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 13, 2025, 8:55 pm

Quick Insight

J K Cements Ltd, with a market capitalization of ₹54,221 Cr. and a share price of 7,025, is currently trading at a P/E ratio of 59.1, showcasing potential overvaluation. However, its ROE of 13.9% and ROCE of 14.0% indicate efficient utilization of capital. With an OPM of 21% and a healthy net profit of ₹872 Cr., the company displays operational strength. The diversified shareholding pattern with promoters at 45.70%, FIIs at 17.71%, DIIs at 22.06%, and the public at 14.52% reflects investor confidence. J K Cements' sound reserves of ₹6,012 Cr. and manageable borrowings of ₹6,028 Cr. position it well for future growth. The high P/BV ratio of 5.87x suggests premium pricing, while the comfortable ICR of 4.87x indicates sufficient debt coverage. Overall, despite the high valuation, the company's operational efficiency and strong financial position could present a compelling investment opportunity for those with a long-term horizon.

Competitors of J K Cements Ltd

All Competitor Stocks of J K Cements Ltd

Quarterly Result

Last Updated: August 1, 2025, 6:45 pm

Below is a detailed analysis of the quarterly data for J K Cements Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 3,353.00 Cr.. The value appears to be declining and may need further review. It has decreased from 3,581.00 Cr. (Mar 2025) to 3,353.00 Cr., marking a decrease of 228.00 Cr..
• For Expenses, as of Jun 2025, the value is 2,665.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 2,816.00 Cr. (Mar 2025) to 2,665.00 Cr., marking a decrease of 151.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 688.00 Cr.. The value appears to be declining and may need further review. It has decreased from 765.00 Cr. (Mar 2025) to 688.00 Cr., marking a decrease of 77.00 Cr..
• For OPM %, as of Jun 2025, the value is 21.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 21.00%.
• For Other Income, as of Jun 2025, the value is 56.00 Cr.. The value appears strong and on an upward trend. It has increased from 46.00 Cr. (Mar 2025) to 56.00 Cr., marking an increase of 10.00 Cr..
• For Interest, as of Jun 2025, the value is 109.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 113.00 Cr. (Mar 2025) to 109.00 Cr., marking a decrease of 4.00 Cr..
• For Depreciation, as of Jun 2025, the value is 146.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 162.00 Cr. (Mar 2025) to 146.00 Cr., marking a decrease of 16.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 489.00 Cr.. The value appears to be declining and may need further review. It has decreased from 535.00 Cr. (Mar 2025) to 489.00 Cr., marking a decrease of 46.00 Cr..
• For Tax %, as of Jun 2025, the value is 34.00%. The value appears to be increasing, which may not be favorable. It has increased from 32.00% (Mar 2025) to 34.00%, marking an increase of 2.00%.
• For Net Profit, as of Jun 2025, the value is 324.00 Cr.. The value appears to be declining and may need further review. It has decreased from 361.00 Cr. (Mar 2025) to 324.00 Cr., marking a decrease of 37.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 41.99. The value appears to be declining and may need further review. It has decreased from 46.64 (Mar 2025) to 41.99, marking a decrease of 4.65.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: July 22, 2025, 3:34 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: July 25, 2025, 2:57 pm

Below is a detailed analysis of the balance sheet data for J K Cements Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 77.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 77.00 Cr..
• For Reserves, as of Mar 2025, the value is 6,012.00 Cr.. The value appears strong and on an upward trend. It has increased from 5,290.00 Cr. (Mar 2024) to 6,012.00 Cr., marking an increase of 722.00 Cr..
• For Borrowings, as of Mar 2025, the value is 6,028.00 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 5,552.00 Cr. (Mar 2024) to 6,028.00 Cr., marking an increase of 476.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 4,564.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3,883.00 Cr. (Mar 2024) to 4,564.00 Cr., marking an increase of 681.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 16,682.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 14,802.00 Cr. (Mar 2024) to 16,682.00 Cr., marking an increase of 1,880.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 9,519.00 Cr.. The value appears strong and on an upward trend. It has increased from 9,298.00 Cr. (Mar 2024) to 9,519.00 Cr., marking an increase of 221.00 Cr..
• For CWIP, as of Mar 2025, the value is 1,317.00 Cr.. The value appears strong and on an upward trend. It has increased from 464.00 Cr. (Mar 2024) to 1,317.00 Cr., marking an increase of 853.00 Cr..
• For Investments, as of Mar 2025, the value is 601.00 Cr.. The value appears strong and on an upward trend. It has increased from 377.00 Cr. (Mar 2024) to 601.00 Cr., marking an increase of 224.00 Cr..
• For Other Assets, as of Mar 2025, the value is 5,244.00 Cr.. The value appears strong and on an upward trend. It has increased from 4,662.00 Cr. (Mar 2024) to 5,244.00 Cr., marking an increase of 582.00 Cr..
• For Total Assets, as of Mar 2025, the value is 16,682.00 Cr.. The value appears strong and on an upward trend. It has increased from 14,802.00 Cr. (Mar 2024) to 16,682.00 Cr., marking an increase of 1,880.00 Cr..

However, the Borrowings (6,028.00 Cr.) are higher than the Reserves (6,012.00 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for J K Cements Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 24, the value is 102.35. This value is within the healthy range. It has increased from 55.17 (Mar 23) to 102.35, marking an increase of 47.18.
• For Diluted EPS (Rs.), as of Mar 24, the value is 102.35. This value is within the healthy range. It has increased from 55.17 (Mar 23) to 102.35, marking an increase of 47.18.
• For Cash EPS (Rs.), as of Mar 24, the value is 176.34. This value is within the healthy range. It has increased from 113.54 (Mar 23) to 176.34, marking an increase of 62.80.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 688.71. It has increased from 600.81 (Mar 23) to 688.71, marking an increase of 87.90.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 688.71. It has increased from 600.81 (Mar 23) to 688.71, marking an increase of 87.90.
• For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 1,495.54. It has increased from 1,257.98 (Mar 23) to 1,495.54, marking an increase of 237.56.
• For PBDIT / Share (Rs.), as of Mar 24, the value is 285.34. This value is within the healthy range. It has increased from 181.41 (Mar 23) to 285.34, marking an increase of 103.93.
• For PBIT / Share (Rs.), as of Mar 24, the value is 211.24. This value is within the healthy range. It has increased from 122.10 (Mar 23) to 211.24, marking an increase of 89.14.
• For PBT / Share (Rs.), as of Mar 24, the value is 151.88. This value is within the healthy range. It has increased from 81.70 (Mar 23) to 151.88, marking an increase of 70.18.
• For Net Profit / Share (Rs.), as of Mar 24, the value is 102.23. This value is within the healthy range. It has increased from 54.24 (Mar 23) to 102.23, marking an increase of 47.99.
• For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 102.35. This value is within the healthy range. It has increased from 55.17 (Mar 23) to 102.35, marking an increase of 47.18.
• For PBDIT Margin (%), as of Mar 24, the value is 19.07. This value is within the healthy range. It has increased from 14.42 (Mar 23) to 19.07, marking an increase of 4.65.
• For PBIT Margin (%), as of Mar 24, the value is 14.12. This value is within the healthy range. It has increased from 9.70 (Mar 23) to 14.12, marking an increase of 4.42.
• For PBT Margin (%), as of Mar 24, the value is 10.15. This value is within the healthy range. It has increased from 6.49 (Mar 23) to 10.15, marking an increase of 3.66.
• For Net Profit Margin (%), as of Mar 24, the value is 6.83. This value is within the healthy range. It has increased from 4.31 (Mar 23) to 6.83, marking an increase of 2.52.
• For NP After MI And SOA Margin (%), as of Mar 24, the value is 6.84. This value is below the healthy minimum of 8. It has increased from 4.38 (Mar 23) to 6.84, marking an increase of 2.46.
• For Return on Networth / Equity (%), as of Mar 24, the value is 14.73. This value is below the healthy minimum of 15. It has increased from 9.09 (Mar 23) to 14.73, marking an increase of 5.64.
• For Return on Capital Employeed (%), as of Mar 24, the value is 14.31. This value is within the healthy range. It has increased from 9.12 (Mar 23) to 14.31, marking an increase of 5.19.
• For Return On Assets (%), as of Mar 24, the value is 5.34. This value is within the healthy range. It has increased from 3.20 (Mar 23) to 5.34, marking an increase of 2.14.
• For Long Term Debt / Equity (X), as of Mar 24, the value is 0.77. This value is within the healthy range. It has decreased from 0.87 (Mar 23) to 0.77, marking a decrease of 0.10.
• For Total Debt / Equity (X), as of Mar 24, the value is 0.97. This value is within the healthy range. It has decreased from 1.07 (Mar 23) to 0.97, marking a decrease of 0.10.
• For Asset Turnover Ratio (%), as of Mar 24, the value is 0.82. It has increased from 0.80 (Mar 23) to 0.82, marking an increase of 0.02.
• For Current Ratio (X), as of Mar 24, the value is 1.30. This value is below the healthy minimum of 1.5. It has increased from 1.27 (Mar 23) to 1.30, marking an increase of 0.03.
• For Quick Ratio (X), as of Mar 24, the value is 0.95. This value is below the healthy minimum of 1. It has increased from 0.93 (Mar 23) to 0.95, marking an increase of 0.02.
• For Inventory Turnover Ratio (X), as of Mar 24, the value is 1.65. This value is below the healthy minimum of 4. It has increased from 1.32 (Mar 23) to 1.65, marking an increase of 0.33.
• For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 14.65. This value is below the healthy minimum of 20. It has decreased from 27.18 (Mar 23) to 14.65, marking a decrease of 12.53.
• For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 8.50. This value is below the healthy minimum of 20. It has decreased from 13.10 (Mar 23) to 8.50, marking a decrease of 4.60.
• For Earning Retention Ratio (%), as of Mar 24, the value is 85.35. This value exceeds the healthy maximum of 70. It has increased from 72.82 (Mar 23) to 85.35, marking an increase of 12.53.
• For Cash Earning Retention Ratio (%), as of Mar 24, the value is 91.50. This value exceeds the healthy maximum of 70. It has increased from 86.90 (Mar 23) to 91.50, marking an increase of 4.60.
• For Interest Coverage Ratio (X), as of Mar 24, the value is 4.87. This value is within the healthy range. It has increased from 4.49 (Mar 23) to 4.87, marking an increase of 0.38.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 2.76. This value is below the healthy minimum of 3. It has increased from 2.34 (Mar 23) to 2.76, marking an increase of 0.42.
• For Enterprise Value (Cr.), as of Mar 24, the value is 35,828.33. It has increased from 26,704.51 (Mar 23) to 35,828.33, marking an increase of 9,123.82.
• For EV / Net Operating Revenue (X), as of Mar 24, the value is 3.10. This value exceeds the healthy maximum of 3. It has increased from 2.75 (Mar 23) to 3.10, marking an increase of 0.35.
• For EV / EBITDA (X), as of Mar 24, the value is 16.25. This value exceeds the healthy maximum of 15. It has decreased from 19.05 (Mar 23) to 16.25, marking a decrease of 2.80.
• For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 2.73. This value is within the healthy range. It has increased from 2.32 (Mar 23) to 2.73, marking an increase of 0.41.
• For Retention Ratios (%), as of Mar 24, the value is 85.34. This value exceeds the healthy maximum of 70. It has increased from 72.81 (Mar 23) to 85.34, marking an increase of 12.53.
• For Price / BV (X), as of Mar 24, the value is 5.87. This value exceeds the healthy maximum of 3. It has increased from 4.82 (Mar 23) to 5.87, marking an increase of 1.05.
• For Price / Net Operating Revenue (X), as of Mar 24, the value is 2.73. This value is within the healthy range. It has increased from 2.32 (Mar 23) to 2.73, marking an increase of 0.41.
• For EarningsYield, as of Mar 24, the value is 0.02. This value is below the healthy minimum of 5. It has increased from 0.01 (Mar 23) to 0.02, marking an increase of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness